Dihydromyricetin Powder Specification

DihydromyricetiDihydromyricetin powder specification review is one of the most important steps before a supplement brand approves a DHM raw material for sampling, pilot production or bulk purchase. A product name and a quoted purity percentage are not enough. Buyers need to understand the assay method, COA structure, botanical or material source, contaminant limits, packaging format, storage conditions and whether the supplier can support repeat orders with consistent documentation.

Dihydromyricetin, also called DHM or ampelopsin in some technical contexts, is commonly discussed as a flavonoid ingredient associated with vine tea extract and high-purity powder applications. Research sources can help buyers understand compound identity and analytical background, but a supplier page should stay focused on raw-material quality and B2B sourcing. It should not turn the ingredient into a consumer health promise.

This article supports Nutrition BioTech’s main Dihydromyricetin Powder Supplier page and the broader DHM supplier article cluster. Use it as a specification checklist when screening samples, reviewing COAs or comparing bulk quotations.

What a Dihydromyricetin Powder Specification Should Include

A useful specification sheet should define what the buyer is actually purchasing. It should be clear enough for the buyer’s QA team, contract manufacturer and purchasing manager to review the same material from the same set of facts.

Core specification items normally include:

product name
alternative name, such as DHM or ampelopsin
botanical or material source when relevant
target assay or purity
test method
appearance
odor or sensory description when applicable
particle size or mesh range
loss on drying or moisture
ash
heavy metals
microbiological limits
residual solvents when relevant
storage condition
shelf life or retest period
packaging format

For high-purity DHM powder, the assay line deserves special attention. A specification that only says “98%” without test method or lot context is weak. Buyers should ask whether the assay is measured by HPLC, whether the value is calculated on an as-is or dried basis, and whether the COA for the shipped batch will match the reviewed sample.

Purity and Assay: Do Not Review the Percentage Alone

The purity number is often the first thing buyers compare, but it should not be reviewed in isolation. A 98% dihydromyricetin powder specification is meaningful only when the supplier can explain how that number is measured and documented.

Ask the supplier:

What method is used for assay?
Is the method HPLC or another analytical method?
Is a chromatogram available for the lot?
Does the COA show the same assay method as the specification sheet?
Is the assay result linked to the exact batch number?
Can third-party testing be arranged before shipment if needed?

The buyer should also check whether the supplier uses consistent terminology. Dihydromyricetin powder, DHM powder, vine tea extract and ampelopsin may appear in related discussions, but they should not be treated as identical without a clear product definition. The specification sheet should remove this ambiguity.

HPLC Review for DHM Powder

HPLC review is a common part of high-purity DHM sourcing because it helps buyers evaluate identity and assay consistency. A COA may list an HPLC result, but the buyer may still need more detail depending on the order size and internal QA process.

Useful HPLC review questions include:

Is the HPLC method listed on the COA?
Does the chromatogram identify the main peak clearly?
Does the supplier compare the sample with a reference standard?
Are there unknown peaks that require explanation?
Is the testing performed in-house, by a third party or both?
Can the supplier provide a recent lot-level chromatogram?

Scientific literature has discussed identification and quantification methods for dihydromyricetin. A B2B buyer can use those sources for analytical background, while still relying on lot-specific supplier documents for purchase decisions.

For article background, see Dihydromyricetin: A review on identification and quantification methods. This type of source should support technical understanding, not finished-product claims.

COA Review: Match the Document to the Batch

A COA should be batch-specific. If the supplier sends a representative COA, the buyer should understand that it may not represent the exact lot that will ship. Representative documents can be useful during early screening, but purchase approval should rely on the actual shipment batch whenever possible.

Check these COA details:

supplier or manufacturer name
product name
batch number
production date
expiration date or retest date
assay result
test method
appearance
moisture or loss on drying
ash
heavy metals
microbiology
residual solvent if applicable
storage condition
quality approval signature or release status

The COA should not contradict the specification sheet. If the specification lists one assay method and the COA lists another, ask for clarification. If the product name differs across invoice, label, specification and COA, ask the supplier to explain the naming structure before the order proceeds.

Contaminant Limits and Risk-Based Testing

DHM powder buyers should review contaminant limits based on intended market, dosage form, supplier history and contract manufacturer requirements. The supplier’s standard specification may be acceptable for one buyer and insufficient for another.

Common review areas include:

lead, arsenic, cadmium and mercury
total plate count
yeast and mold
E. coli
Salmonella
Staphylococcus aureus where applicable
residual solvents if extraction solvents are used
pesticide residues where relevant
allergens or GMO statements when requested

The buyer should avoid assuming that “food grade” or “supplement grade” automatically meets every destination market requirement. If the finished product will be sold in the United States, the brand and manufacturer should align raw-material specifications with their quality system and applicable supplement manufacturing rules.

Particle Size and Physical Handling

Particle size is easy to overlook, but it can affect blending, encapsulation, tablet compression and powder handling. A DHM powder specification should indicate whether the material is a fine powder, whether a mesh range is controlled and whether the supplier can support a consistent physical profile across batches.

Questions to ask:

Is particle size tested or described only visually?
Can the supplier provide a mesh specification?
Does the powder have flow challenges during handling?
Is the powder hygroscopic or sensitive to moisture?
Will the buyer need milling, sieving or blending adjustments?

These points matter most when a brand is moving from sample approval into production. A lab sample may look acceptable, while a larger batch may reveal flow, dusting or blending concerns.

Packaging and Labeling Information

Bulk DHM powder should arrive in packaging that protects the material and supports receiving inspection. Buyers should ask for standard packaging details before purchase.

Useful packaging details include:

net weight per drum, carton or bag
inner bag material
outer container type
tamper-evident closure when applicable
batch label information
storage symbol or handling statement
palletization for larger shipments
moisture and light protection

For international orders, packaging also connects with export documents. The invoice, packing list, label and COA should use aligned product and batch information. Small inconsistencies may slow customs review or receiving QA.

Storage and Shelf-Life Review

Dihydromyricetin powder specification review should include storage and shelf-life conditions. Buyers should ask whether the stated shelf life depends on unopened original packaging, cool and dry storage, light protection or other conditions.

Clarify:

recommended storage temperature
humidity protection
light protection
whether refrigeration is needed
shelf life or retest period
whether stability data is available
whether the supplier can provide a retest COA for older inventory

Do not assume a long shelf life without supporting documentation. If the supplier offers old stock at a lower price, review retest date, storage history and updated testing before accepting the order.

Supplier Consistency Across Repeat Orders

A good initial specification is only part of the sourcing decision. Supplement brands also need repeatability. If a buyer plans to build a product around DHM powder, the supplier should be able to support future batches with the same target grade, documentation style and communication process.

Ask:

Is the material produced regularly or only occasionally?
Can the supplier reserve the same grade for repeat orders?
Are raw-material sources seasonal?
Does the supplier notify buyers of specification changes?
Can the supplier provide batch-to-batch COA comparison?

Repeatability becomes more important after a product launch. Changing supplier, grade or assay method later can create reformulation, documentation and label-review work.

How to Use a Specification During Sample Approval

The specification should guide the sample approval process. Buyers should not approve a sample only by appearance or price. A stronger process connects sample, COA, specification and future bulk shipment.

A practical sample workflow:

request the specification sheet
request a representative COA
receive and label the sample
compare sample label with documents
review assay and method
check contaminant limits
test internally or through a third party if needed
confirm bulk packaging and MOQ
approve, reject or request clarification

If the buyer approves a sample, the purchase order should state that the bulk batch must match the agreed specification. This helps prevent a situation where the sample is one grade and the shipment is another.

Nutrition BioTech DHM Specification Support

Nutrition BioTech can support DHM powder sourcing with specification review, COA discussion, sample coordination and bulk-order communication. Buyers can start with the main Dihydromyricetin Powder Supplier page or review Dihydromyricetin 98% for product-level information.

For supplier screening, also review:

When contacting a supplier, include target assay, destination market, intended dosage form, estimated order quantity, document requirements and testing expectations. This gives the supplier enough context to respond with a relevant specification package.

FAQ

What is the most important line in a dihydromyricetin powder specification?

The assay line is important, but it should be reviewed together with method, batch number, COA, contaminant limits and storage requirements.

Is HPLC necessary for DHM powder?

For high-purity DHM powder, HPLC assay review is commonly expected. Buyers should ask for method clarity and lot-level documentation.

Should buyers accept a representative COA?

A representative COA can support early screening, but final purchase approval should use the actual batch COA whenever possible.

What should be checked before a bulk order?

Check product name, assay, test method, COA, heavy metals, microbiology, residual solvents if relevant, packaging, lead time and export documents.

Can specification pages discuss DHM research?

Yes, but only as ingredient or analytical background. Do not use research references to imply that a supplier’s raw material guarantees consumer health outcomes.